Condition: Cardiovascular · Metabolic Disease · Dyslipidemias · Sponsor: CRISPR Therapeutics AG
This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available treatments.
This description comes directly from the study's public registry record.
Clinical Trials · 877-214-4634 · medicalaffairs@crisprtx.com
Always discuss trial participation with your own doctor first.
| Integrity Clinical Research | Hialeah, Florida, United States | Recruiting |
| Jacksonville Center for Clinical Research | Jacksonville, Florida, United States | Recruiting |
| Flourish Orlando | Orlando, Florida, United States | Recruiting |
| United Medical Research | Port Orange, Florida, United States | Recruiting |
| University of Rochester | Rochester, New York, United States | Not Yet Recruiting |
| Duke Early Phase Clinical Research | Durham, North Carolina, United States | Recruiting |
| Peters Medical Research | High Point, North Carolina, United States | Recruiting |
| Cleveland Clinic | Cleveland, Ohio, United States | Not Yet Recruiting |
| Oregon Health & Science University (OHSU) | Portland, Oregon, United States | Not Yet Recruiting |
| Royal Adelaide | Adelaide, Australia | Recruiting |
| CORE Research | Brisbane, Australia | Not Yet Recruiting |
| Royal Prince Alfred Hospital | Camperdown, Australia | Not Yet Recruiting |
+ 7 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07491172